Qube Research & Technologies LTD Liquidia Corp Transaction History

Qube Research & Technologies LTD

  • $62.3 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$11.35 - $16.73 $862,350 - $1.27 Million
75,978 New
75,978 $1.12 Million
Q2 2022

Aug 15, 2022
SELL
$3.37 - $7.55 $178,758 - $400,482
-53,044 Closed
0 $0
Q1 2022

May 09, 2022
BUY
$5.14 - $7.38 $214,476 - $307,945
41,727 Added 368.71%
53,044 $381,000
Q4 2021

Feb 01, 2022
BUY
$2.71 - $5.17 $30,669 - $58,508
11,317 New
11,317 $55,000

Others Institutions Holding LQDA

# of Institutions
162
Shares Held
36M
Call Options Held
1.79M
Put Options Held
380K
View Full List

About Liquidia Corp

LQDA Quotes by TradingView
  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email